PerkinElmer’s Ivis Lumina series III benchtop platform is for oncology, infectious disease, and drug discovery and efficacy research. The system integrates bioluminescence and full spectral fluorescence in vivo imaging technologies, providing an expandable and sensitive benchtop imaging platform.
The Lumina series III is available in the Ivis Lumina III, Ivis Lumina K, Lumina XR, and Lumina LT models. The Ivis series III benchtop platform performs multimodality imaging, which provides an opportunity to noninvasively generate anatomic, functional, and molecular endpoints simultaneously. This leads to data sets that can be used to make decisions in drug research.
The series III offers a full spectrum of wavelengths to perform most in vivo optical applications, supporting a wide range of in vivo experimental models. It is equipped with up to 26 filter sets that can be used to image reporters that emit from green to near-infrared in tunable precision enabled by PerkinElmer’s Compute Pure Spectrum algorithms.
The Ivis Lumina series III can acquire images at multiple wavelengths to calculate concentrations of different fluorescent components in every pixel of an image. This results in the quantitative separation of spectral components within an image.
For research use only.
PerkinElmer, 203-925-4602